---
title: "Parents’ perceptions and acceptability of the HPV vaccine in rural Kabompo, Zambia"
id: "medrxiv-2-parents-perceptions-and-acceptability-of-the-human-papillomavirus-vaccine-in"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-2-parents-perceptions-and-acceptability-of-the-human-papillomavirus-vaccine-in"
content_type: "clinical_feed_article"
specialty: "Pediatrics"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.14.26362793v1?rss=1"
published_at: "2026-09-17T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Parents’ perceptions and acceptability of the HPV vaccine in rural Kabompo, Zambia
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-2-parents-perceptions-and-acceptability-of-the-human-papillomavirus-vaccine-in
- **Specialty:** [Pediatrics](https://medichelpline.com/clinical-feed/pediatrics.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.14.26362793v1?rss=1)
- **Published At:** 2026-09-17T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Study setting: descriptive phenomenological study at Kabompo Hospital Affiliated Health Centre in Kabompo district, North-Western Province, Zambia, conducted June–August 2025. - Participants: twenty parents and legal guardians of girls aged 9–14 years selected purposively using maximum variation sampling and interviewed in English or Luvale. - Methods: in-depth audio-recorded interviews transcribed verbatim and analysed using Colaizzi’s seven-step method with QDA Miner Lite. - Coverage context: by 2024, only **59%** of eligible girls in Kabompo had received the HPV vaccine, below the global target. - Five analytic themes: knowledge and awareness of **HPV** and its vaccine; perceptions of safety and efficacy; sociocultural and religious influences; the role of **health workers**; and barriers to access. - Knowledge gaps: most parents knew the vaccine prevents **cervical cancer**, but few explained HPV’s role in carcinogenesis or could state the dosing schedule; several first learned about vaccination at the point of service. - Safety concerns: prominent fear of infertility and perceptions that the vaccine was too new drove hesitancy. - Sociocultural and religious factors: beliefs in divine protection, preference for herbal remedies, and concern that vaccination condones early sexual activity influenced decision-making. - Trusted sources and decision drivers: **health workers** were the most trusted information source and often decisive in parental decisions. - Access barriers: distance to services, transport costs, fear of injections, and incomplete dosing limited uptake. - Acceptability versus uptake: stated acceptability was generally high but did not always translate into vaccination, indicating an intention–behaviour gap that information campaigns alone may not resolve. - Data sharing: primary interview transcripts are not publicly available for confidentiality reasons; de-identified excerpts appear in the manuscript and data access requests can be made to the University of Zambia Biomedical Research Ethics Committee (UNZABREC).
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=8Yw4UwdO0rlcak.FCofb6.LM21PrJ9nQcCQaQpM_NMg-1789721064.4416447-1.2.1.1-.OLegblIv1efDpTsVQm5LrHs7EtP_LWWM8Bsdf41iMhbKnN8vRsRKf_MQxTlp77x) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.09.14.26362793v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Parents’ perceptions and acceptability of the human papillomavirus vaccine in rural Zambia: a descriptive phenomenological study at Kabompo Hospital Affiliated Health Centre [ View ORCID Profile](http://orcid.org/0009-0001-0634-036X)Sondashi Bombwe, Sebean Mayimbo, [ View ORCID Profile](http://orcid.org/0000-0002-6846-267X)Stella Nankamba doi: https://doi.org/10.64898/2026.09.14.26362793 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Sondashi Bombwe 1 Zambia Ministry of Health; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Sondashi%2BBombwe%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Bombwe%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASondashi%2BBombwe%2B) * [ORCID record for Sondashi Bombwe](http://orcid.org/0009-0001-0634-036X "Open in new tab") * For correspondence: slumbwe@gmail.com Sebean Mayimbo 2 University of Zambia * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Sebean%2BMayimbo%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Mayimbo%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASebean%2BMayimbo%2B) Stella Nankamba 2 University of Zambia * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Stella%2BNankamba%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Nankamba%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AStella%2BNankamba%2B) * [ORCID record for Stella Nankamba](http://orcid.org/0000-0002-6846-267X "Open in new tab") * [Abstract](https://www.medrxiv.org/content/10.64898/2026.09.14.26362793v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1302637/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.09.14.26362793v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1302637/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.09.14.26362793v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1302637/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.09.14.26362793v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1302637/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.09.14.26362793v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1302637/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Cervical cancer is a leading cause of cancer death among women in Zambia, and vaccination of girls aged 9-14 years against human papillomavirus (HPV) is the principal primary prevention strategy. Because the vaccine is given to minors, uptake depends on parental consent, which is shaped by how parents perceive the vaccine. In Kabompo, a rural, ethnically diverse district of North-Western Province, only 59% of eligible girls had been vaccinated by 2024, well below the global target, yet no qualitative evidence existed on how parents in such settings understand and decide about the vaccine. We conducted a descriptive phenomenological study at Kabompo Hospital Affiliated Health Centre between June and August 2025. Twenty parents and legal guardians of girls aged 9-14 years were purposively selected using maximum variation sampling and interviewed in depth in English or Luvale. Interviews were audio-recorded, transcribed verbatim and analysed using Colaizzi's seven-step method with QDA Miner Lite. Five themes were generated: knowledge and awareness of HPV and its vaccine; perceptions of safety and efficacy; sociocultural and religious influences; the role of health workers; and barriers to access. Most parents knew the vaccine prevents cervical cancer, but few could explain how HPV causes cancer or state the schedule, and several first learned about the vaccine at the point of service. Fear of infertility was the most prominent concern, alongside unease that the vaccine was too new. Religious framings of divine protection, preference for herbal remedies, and concern that vaccination condones early sexual activity shaped decisions. Health workers were the most trusted source of information and were often decisive. Distance, transport costs, fear of injections and incomplete dosing limited uptake. Stated acceptability was high but did not consistently translate into vaccination, indicating an intention-behaviour gap that information campaigns alone are unlikely to close. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: University of Zambia Biomedical Research Ethics Committee gave approval for this work I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability The data underlying this study cannot be shared publicly due to ethical restrictions and concerns regarding participant confidentiality. The dataset consists of transcripts from in-depth qualitative interviews that contain sensitive personal beliefs and potentially identifying contextual information. Public sharing of these transcripts would compromise the privacy of the parents and guardians who participated, violating the conditions of the informed consent and the ethical approval granted by the University of Zambia Biomedical Research Ethics Committee (UNZABREC). De-identified, representative excerpts of the data are available within the manuscript. Researchers who meet the criteria for access to confidential qualitative data may submit data access requests to the University of Zambia Biomedical Research Ethics Committee (UNZABREC) at unzarec{at}unza.zm, or by mail at Ridgeway Campus, P.O. Box 50110, Lusaka, Zambia. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.09.14.26362793v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.09.16.26363222v1 "Multi-population genome-wide association meta-analysis of acute and chronic pancreatitis")[Next ](https://www.medrxiv.org/content/10.64898/2026.09.16.26363055v1 "Psychological factors contribute more to chronic low back pain than spine pathology: An LLM-based analysis of radiology reports") Posted September 17, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.09.14.26362793v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/09/17/2026.09.14.26362793.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.09.14.26362793v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/09/17/2026.09.14.26362793.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Parents’ perceptions and acceptability of the human papillomavirus vaccine in rural Zambia: a descriptive phenomenological study at Kabompo Hospital Affiliated Health Centre Sondashi Bombwe, Sebean Mayimbo, Stella Nankamba medRxiv 2026.09.14.26362793; doi: https://doi.org/10.64898/2026.09.14.26362793 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.14.26362793v1%26text%3DParents%25E2%2580%2599%2520perceptions%2520and%2520acceptability%2520of%2520the%2520human%2520papillomavirus%2520vaccine%2520in%2520rural%2520Zambia%253A%2520a%2520descriptive%2520phenomenological%2520study%2520at%2520Kabompo%2520Hospital%2520Affiliated%2520Health%2520Centre "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.14.26362793v1%26t%3DParents%25E2%2580%2599%2520perceptions%2520and%2520acceptability%2520of%2520the%2520human%2520papillomavirus%2520vaccine%2520in%2520rural%2520Zambia%253A%2520a%2520descriptive%2520phenomenological%2520study%2520at%2520Kabompo%2520Hospital%2520Affiliated%2520Health%2520Centre "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.14.26362793v1%26title%3DParents%25E2%2580%2599%2520perceptions%2520and%2520acceptability%2520of%2520the%2520human%2520papillomavirus%2520vaccine%2520in%2520rural%2520Zambia%253A%2520a%2520descriptive%2520phenomenological%2520study%2520at%2520Kabompo%2520Hospital%2520Affiliated%2520Health%2520Centre%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.14.26362793v1%26title%3DParents%25E2%2580%2599%2520perceptions%2520and%2520acceptability%2520of%2520the%2520human%2520papillomavirus%2520vaccine%2520in%2520rural%2520Zambia%253A%2520a%2520descriptive%2520phenomenological%2520study%2520at%2520Kabompo%2520Hospital%2520Affiliated%2520Health%2520Centre "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.09.14.26362793) ## Subject Area * [Sexual and Reproductive Health ](https://www.medrxiv.org/collection/sexual-and-reproductive-health) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (618) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (903) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (334) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4822) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (479) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (416) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (650) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1632) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15966) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (33) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1204) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7057) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (733) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1066) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5054) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1436) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1773) * [Hematology](https://www.medrxiv.org/collection/hematology) (587) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1347) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16299) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1174) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (671) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (155) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (725) * [Neurology](https://www.medrxiv.org/collection/neurology) (7288) * [Nursing](https://www.medrxiv.org/collection/nursing) (368) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1082) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1243) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1005) * [Oncology](https://www.medrxiv.org/collection/oncology) (3613) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1054) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (398) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (457) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (472) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (139) * [Pathology](https://www.medrxiv.org/collection/pathology) (709) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1805) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (737) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (768) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5911) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9767) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2429) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1455) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1249) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (642) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (773) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (578) * [Surgery](https://www.medrxiv.org/collection/surgery) (780) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (107) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (305) * [Urology](https://www.medrxiv.org/collection/urology) (292) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post peer reviews of manuscripts they are evaluating _There is no TRiP material for this paper._ Community Reviews medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Community reviews for this article: _There are no community reviews for this paper._ Automated Evaluations Certain services provide automated analysis
## Related Clinical Research

- [Physical activity, sedentary behavior, and sleep after childhood cancer: device-based findings fro](https://medichelpline.com/clinical-feed/medrxiv-2-physical-activity-sedentary-behavior-and-sleep-in-everyday-life-after-childhood.md)
- [Global burden and future trends of diabetes mellitus in adolescents (1990–2040): GBD 2023 analysis](https://medichelpline.com/clinical-feed/plos-one-5-global-burdens-of-diabetes-mellitus-in-adolescents-from-1990-to-2023-and-future.md)
- [FDA approves Fayuvi gene therapy for Sanfilippo syndrome type A — first approved treatment](https://medichelpline.com/clinical-feed/stat-news-2-stat-fda-approves-a-new-gene-therapy-for-sanfilippo-syndrome-an-ultra-rare.md)
- [Recent Nearby Gun Violence and Risk of Recurrent Psychiatric Exacerbation in Children and Adolesce](https://medichelpline.com/clinical-feed/medrxiv-5-recent-nearby-gun-violence-and-recurrent-psychiatric-exacerbation-in-children.md)
- [Orexin agonist ALKS 7290 shows ADHD symptom improvement in early Phase 1 trial](https://medichelpline.com/clinical-feed/stat-news-0-stat-alkermes-orexin-agonist-shows-potential-to-treat-adhd-in-early-stage-trial.md)

## Navigation
- [← Back to Pediatrics Feed](https://medichelpline.com/clinical-feed/pediatrics.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.